Skip to NavigationSkip to content

Takeda sheds 30 products in emerging markets in $200m deal

Published on 15/10/19 at 04:44pm

Takeda has sold selected prescription and over the counter products to Acino in the Near East, Middle East and Africa as it looks to trim down its debt and portfolio following its $62 billion acquisition of Shire.

The products in question are currently grouped within Takeda’s ‘Growth and Emerging Markets’ business unit with the company noting that these are primarily outside of its core business areas.

Acino is a Swiss pharmaceutical company that will acquire the assets which additionally would pick up key gastroenterology products which would be considered part of Takeda’s core areas. Other therapeutic areas represented in the portfolio are cardiovascular, pain management and respiratory.

In return for approximately 30 products that the Basel-headquartered Acino will acquire, Takeda will be payed in excess of $200 million.

Acino have stated that the deal will ultimately strengthen their position in several ‘key markets’, including UAE, Egypt, Saudi Arabia, Turkey, Ukraine and South Africa.

It has also been revealed that the two companies have also entered a ‘multi-year’ manufacturing and supply agreement which will see Takeda manufacture the products on behalf of Acino. Additionally Takeda expects sales and marketing professionals currently responsible for the portfolio to transition to Acino at the closing of the transaction.

The deal is slated to close in the fourth quarter of this financial year.

Both Takeda’s debt and portfolio grew substantially after the $62 billion acquisition of Shire which has led the company to essentially sell off and ‘shed’ certain older products in its portfolio.

One example is the sale of Xildra (liftegrast ophthalmic solution) for $3.4 billion as well as the divestment of TachoSil Fibrin Sealant Patch to Ethicon, a subsidiary of Johnson & Johnson, for $400 million.

Nik Kiran

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches